Literature DB >> 9570518

Differential effect of anti-B7-1 and anti-M150 antibodies in restricting the delivery of costimulatory signals from B cells and macrophages.

J N Agrewala1, S Suvas, R K Verma, G C Mishra.   

Abstract

B7-1 and M150 are potent costimulatory molecules expressed on B cells and macrophages. We have examined the capacity of Abs against B7-1 and M150 in differentially inhibiting the costimulatory signals delivered by macrophages and B cells to OVA-specific CD4+ T cells. The anti-B7-1 Ab significantly blocked the proliferation of Th cells, MLR, T cell help to B cells, and secretion of IFN-gamma when B cells were used to provide costimulation, but not when macrophages were used. In contrast, anti-M150 Ab significantly decreased the proliferation of Th cells, MLR, and production of IFN-gamma, when macrophages were utilized to provide costimulatory signals, but not when B cells were used as APC. However, when macrophages activated with IFN-gamma were used as a source of costimulation, like anti-M150 Ab, Ab to B7-1 also down-regulated the activation of Th cells. The significance of this finding is that M150 is a potent first costimulatory signal for initiating proliferation and secretion of IFN-gamma and providing cognate help for B cells by Th cells when the macrophage is used as an accessory cell. M150-induced IFN-gamma production induces the expression of B7-1 on the surface of macrophages, which then delivers a second cosignal for Th cells. B7-1 works efficiently when B cell provides cosignal. Both of the molecules promote Th1 activity, as evidenced by the inhibition of the secretion of IFN-gamma but not IL-4 by Th cells with anti-M150 and B7-1 Abs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570518

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Delivery of antigen in allogeneic cells preferentially generates CD(4+) Th1 cells.

Authors:  J N Agrewala; S Suvas; V Singh; H Vohra
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

2.  Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells.

Authors:  V Raghavendra; V Singh; A V Shaji; H Vohra; S K Kulkarni; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Antibody responses to 43 and 48 kDa antigens of blood-stage Plasmodium berghei in Balb/c mice.

Authors:  Upma Bagai; Anil Pawar; Vineet Kumar
Journal:  J Parasit Dis       Date:  2010-10-08

4.  Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists.

Authors:  V Raghavendra; V Singh; S K Kulkarni; J N Agrewala
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

5.  Truncated hemoglobin, HbN, is post-translationally modified in Mycobacterium tuberculosis and modulates host-pathogen interactions during intracellular infection.

Authors:  Swati Arya; Deepti Sethi; Sandeep Singh; Mangesh Dattu Hade; Vijender Singh; Preeti Raju; Sathi Babu Chodisetti; Deepshikha Verma; Grish C Varshney; Javed N Agrewala; Kanak L Dikshit
Journal:  J Biol Chem       Date:  2013-08-27       Impact factor: 5.157

6.  Modulation of the expression of M150 on macrophages by Th1/Th2 cytokines and co-stimulatory molecules CD40, B7-1, B7-2 and ICAM-1.

Authors:  S Suvas; H Vohra; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

7.  Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.

Authors:  Varun Dwivedi; Arif Khan; Azevedo Vasco; Nishat Fatima; Vishal Kumar Soni; Anil Dangi; Shailja Misra-Bhattacharya; Mohammad Owais
Journal:  Pharm Res       Date:  2008-06-13       Impact factor: 4.200

8.  Regulatory role of pro-Th1 and pro-Th2 cytokines in modulating the activity of Th1 and Th2 cells when B cell and macrophages are used as antigen presenting cells.

Authors:  Vinod Singh; Javed N Agrewala
Journal:  BMC Immunol       Date:  2006-08-07       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.